<VariationArchive VariationID="6594" VariationName="NM_003742.4(ABCB11):c.2783_2787dup (p.Lys930fs)" VariationType="Duplication" Accession="VCV000006594" Version="13" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-17" DateCreated="2015-10-11" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21633" VariationID="6594">
      <GeneList>
        <Gene Symbol="ABCB11" FullName="ATP binding cassette subfamily B member 11" GeneID="8647" HGNC_ID="HGNC:42" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NW_003315909.1" start="107408" stop="123061" display_start="107408" display_stop="123061" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="168915390" stop="169031324" display_start="168915390" display_stop="169031324" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="169779448" stop="169887832" display_start="169779448" display_stop="169887832" Strand="-" />
          </Location>
          <OMIM>603201</OMIM>
        </Gene>
        <Gene Symbol="LOC126806400" FullName="CDK7 strongly-dependent group 2 enhancer GRCh37_chr2:169791870-169793069" GeneID="126806400" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="168935360" stop="168936559" display_start="168935360" display_stop="168936559" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NW_003315909.1" start="121987" stop="123186" display_start="121987" display_stop="123186" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_003742.4(ABCB11):c.2783_2787dup (p.Lys930fs)</Name>
      <CanonicalSPDI>NC_000002.12:168936256:ATCTC:ATCTCATCTC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="168936256" stop="168936257" display_start="168936256" display_stop="168936257" variantLength="5" positionVCF="168936256" referenceAlleleVCF="T" alternateAlleleVCF="TATCTC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="169792766" stop="169792767" display_start="169792766" display_stop="169792767" variantLength="5" positionVCF="169792766" referenceAlleleVCF="T" alternateAlleleVCF="TATCTC" />
      </Location>
      <ProteinChange>K930fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1199" sequenceAccession="LRG_1199" change="g.100136_100140dup">
            <Expression>LRG_1199:g.100136_100140dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1199t1" sequenceAccession="LRG_1199t1" change="c.2783_2787dup">
            <Expression>LRG_1199t1:c.2783_2787dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1199p1" sequenceAccession="LRG_1199p1" change="p.Lys930fs">
            <Expression>LRG_1199p1:p.Lys930fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.169792767_169792771dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.169792767_169792771dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.168936257_168936261dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.168936257_168936261dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007374.2" sequenceAccession="NG_007374" sequenceVersion="2" change="g.100136_100140dup">
            <Expression>NG_007374.2:g.100136_100140dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003742.4" sequenceAccession="NM_003742" sequenceVersion="4" change="c.2783_2787dup" MANESelect="true">
            <Expression>NM_003742.4:c.2783_2787dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003733.2" sequenceAccession="NP_003733" sequenceVersion="2" change="p.Lys930fs">
            <Expression>NP_003733.2:p.Lys930fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003742.2" sequenceAccession="NM_003742" sequenceVersion="2" change="c.2783_2787dup">
            <Expression>NM_003742.2:c.2783_2787dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603201.0008" DB="OMIM" />
        <XRef Type="rs" ID="752919965" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003742.4(ABCB11):c.2783_2787dup (p.Lys930fs) AND Progressive familial intrahepatic cholestasis type 2" Accession="RCV000006973" Version="4">
        <ClassifiedConditionList TraitSetID="1824">
          <ClassifiedCondition DB="MedGen" ID="C3489789">Progressive familial intrahepatic cholestasis type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003742.4(ABCB11):c.2783_2787dup (p.Lys930fs) AND not provided" Accession="RCV000732890" Version="9">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-06" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003742.4(ABCB11):c.2783_2787dup (p.Lys930fs) AND Benign recurrent intrahepatic cholestasis type 2" Accession="RCV003460430" Version="2">
        <ClassifiedConditionList TraitSetID="6596">
          <ClassifiedCondition DB="MedGen" ID="C2608083">Benign recurrent intrahepatic cholestasis type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-25" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2015-10-11" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16039748</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18395098</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20232290</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24115678</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26678486</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27368585</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ABCB11</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="1824" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1429" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Progressive familial intrahepatic cholestasis type 2</ElementValue>
                <XRef ID="MONDO:0011156" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PFIC2</ElementValue>
                <XRef Type="MIM" ID="601847" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1288" />
                <XRef ID="1288" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of ATP8B1 deficiency ranges from severe through moderate to mild. Severe ATP8B1 deficiency is characterized by infantile-onset cholestasis that progresses to cirrhosis, hepatic failure, and early death. Although mild-to-moderate ATP8B1 deficiency initially was thought to involve intermittent symptomatic cholestasis with a lack of hepatic fibrosis, it is now known that hepatic fibrosis may be present early in the disease course. Furthermore, in some persons with ATP8B1 deficiency the clinical findings can span the phenotypic spectrum, shifting over time from the mild end of the spectrum (episodic cholestasis) to the severe end of the spectrum (persistent cholestasis). Sensorineural hearing loss (SNHL) is common across the phenotypic spectrum.</Attribute>
                <XRef ID="NBK1297" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301474</ID>
                <ID Source="BookShelf">NBK1297</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36108118</ID>
                <ID Source="BookShelf">NBK584020</ID>
              </Citation>
              <XRef ID="79304" DB="Orphanet" />
              <XRef ID="C3489789" DB="MedGen" />
              <XRef ID="MONDO:0011156" DB="MONDO" />
              <XRef Type="MIM" ID="601847" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6596" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="794" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Benign recurrent intrahepatic cholestasis type 2</ElementValue>
                <XRef ID="MONDO:0011559" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Recurrent familial intrahepatic cholestasis 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BRIC2</ElementValue>
                <XRef Type="MIM" ID="605479" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10029" />
                <XRef ID="10029" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of ATP8B1 deficiency ranges from severe through moderate to mild. Severe ATP8B1 deficiency is characterized by infantile-onset cholestasis that progresses to cirrhosis, hepatic failure, and early death. Although mild-to-moderate ATP8B1 deficiency initially was thought to involve intermittent symptomatic cholestasis with a lack of hepatic fibrosis, it is now known that hepatic fibrosis may be present early in the disease course. Furthermore, in some persons with ATP8B1 deficiency the clinical findings can span the phenotypic spectrum, shifting over time from the mild end of the spectrum (episodic cholestasis) to the severe end of the spectrum (persistent cholestasis). Sensorineural hearing loss (SNHL) is common across the phenotypic spectrum.</Attribute>
                <XRef ID="NBK1297" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301474</ID>
                <ID Source="BookShelf">NBK1297</ID>
              </Citation>
              <XRef ID="65682" DB="Orphanet" />
              <XRef ID="99961" DB="Orphanet" />
              <XRef ID="C2608083" DB="MedGen" />
              <XRef ID="MONDO:0011559" DB="MONDO" />
              <XRef Type="MIM" ID="605479" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27169" SubmissionDate="2016-10-29" DateLastUpdated="2015-10-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603201.0008_CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2" title="ABCB11, 5-BP INS, GAGAT_CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2" />
        <ClinVarAccession Accession="SCV000027169" DateUpdated="2015-10-11" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 5-bp insertion in exon 21 of the ABCB11 gene that was identified in compound heterozygous state in a patient with progressive familial intrahepatic cholestasis-2 (PFIC2; 601847) by Noe et al. (2005), see 603201.0005.</Attribute>
              <Citation>
                <ID Source="PubMed">16039748</ID>
              </Citation>
              <XRef DB="OMIM" ID="601847" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCB11" />
          </GeneList>
          <Name>ABCB11, 5-BP INS, GAGAT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP INS, GAGAT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603201.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1677878" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-16" DateCreated="2018-12-16">
        <ClinVarSubmissionID localKey="69508_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000860888" DateUpdated="2018-12-16" DateCreated="2018-12-16" Type="SCV" Version="1" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16039748</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24115678</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27368585</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL ClinVar v180209 classification definitions</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/kvqgb2ud/egl_clinvar_v180209_classification_definitions.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCB11" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="ATCTC" referenceAllele="-" start="169792767" stop="169792771" variantLength="5" />
            <GeneLocation>NM_003742.2:Ex22</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI035823" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ABCB11</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7552139" SubmissionDate="2023-09-20" DateLastUpdated="2023-09-23" DateCreated="2023-09-23">
        <ClinVarSubmissionID localKey="GDXSV:288369" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004035424" DateUpdated="2023-09-23" DateCreated="2023-09-23" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24115678, 16039748, 26678486, 28733223, 29625052, 27368585, 34016879)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCB11" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2705077</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003742.2:c.2783_2787dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_219_20230920054203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2743645" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4835487|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001408610" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18395098</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20232290</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16039748</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26678486</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys930Glufs*79) in the ABCB11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCB11 are known to be pathogenic (PMID: 18395098, 20232290). This variant is present in population databases (rs752919965, gnomAD 0.002%). This premature translational stop signal has been observed in individuals with progressive familial intrahepatic cholestasis 2 (PMID: 16039748, 26678486). This variant is also known as K930X and c.2787_2788insGAGAT. ClinVar contains an entry for this variant (Variation ID: 6594). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCB11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.169792766_169792767insATCTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7865381" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_003742.4:c.2783_2787dup|OMIM:605479" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004214834" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003742.4:c.2783_2787dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605479" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7865381" TraitType="Disease" MappingType="XRef" MappingValue="605479" MappingRef="OMIM">
        <MedGen CUI="C2608083" Name="Benign recurrent intrahepatic cholestasis type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1677878" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27169" TraitType="Disease" MappingType="Name" MappingValue="CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2" MappingRef="Preferred">
        <MedGen CUI="C3489789" Name="Progressive familial intrahepatic cholestasis type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2743645" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7552139" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

